Phase Genomics, founded in 2015, is a pioneering company in the Biotechnology and Clean Energy sectors, headquartered in the United States. The company is renowned for its tagline, "Blueprints for Biology™: Hi-C Genomics, Metagenomics, and Epigenomics", which encapsulates its commitment to advancing the field through innovative genomic analysis techniques.
Utilizing cutting-edge Hi-C and proximity-ligation technologies, Phase Genomics specializes in chromosome-scale genome assembly and metagenomic deconvolution. It offers a broad range of sophisticated laboratory and computational solutions, including Hi-C kits tailored for various biological samples and leading-edge genome assembly software. This enables its clients, both in academic and commercial domains, to undertake comprehensive structural genomic analyses.
The company's recent financing—a $1.50M grant from the Bill & Melinda Gates Foundation on 04 March 2024—attests to its strategic importance and potential for impact in the realms of scientific research and innovation.